NCT06609070View on ClinicalTrials.gov

CHG0521 Oral Coating in Patients with Solid Tissue Tumor/Recurrent/Metastatic TSCC

NANot yet recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

October 15, 2024

Primary Completion Date

August 31, 2026

Study Completion Date

August 31, 2026

Conditions
Squamous Cell CarcinomaSquamous Cell Carcinoma of the Oral Cavity
Interventions
DRUG

CHG0521 Oral Coating

The subjects will receive an oral coating of CHG0521 in the form of drops, in addition to the clinician\'s standard treatment regimen, for a duration of 6 months or until confirmed progression, unacceptable toxicity, or any criteria for withdrawal from the trial.

All Listed Sponsors
lead

Guangzhou University of Traditional Chinese Medicine

OTHER

NCT06609070 - CHG0521 Oral Coating in Patients with Solid Tissue Tumor/Recurrent/Metastatic TSCC | Biotech Hunter | Biotech Hunter